H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares changing hands.
H. Lundbeck A/S Trading Down 0.0 %
The company has a debt-to-equity ratio of 0.32, a current ratio of 1.15 and a quick ratio of 0.71. The stock has a 50-day moving average price of $22.00 and a two-hundred day moving average price of $22.00. The stock has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Articles
- Five stocks we like better than H. Lundbeck A/S
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- Financial Services Stocks Investing
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- Technology Stocks Explained: Here’s What to Know About Tech
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
